| gga04080 |
Neuroactive ligand-receptor interaction |
60 |
3.9 |
5.2E-13 |
51 |
5.4 |
2E-17 |
| gga04060 |
Cytokine-cytokine receptor interaction |
40 |
2.6 |
0.00045 |
19 |
2 |
0.013 |
| gga04020 |
Calcium signaling pathway |
33 |
2.2 |
0.000034 |
29 |
3.1 |
5.7E-08 |
| gga04010 |
MAPK signaling pathway |
31 |
2 |
0.018 |
11 |
1.2 |
0.039 |
| gga04510 |
Focal adhesion |
27 |
1.8 |
0.023 |
14 |
1.5 |
0.024 |
| gga04810 |
Regulation of actin cytoskeleton |
27 |
1.8 |
0.049 |
14 |
1.5 |
0.032 |
| gga04514 |
Cell adhesion molecules (CAMs) |
22 |
1.4 |
0.0042 |
13 |
1.4 |
0.038 |
| gga04310 |
Wnt signaling pathway |
21 |
1.4 |
0.035 |
14 |
1.5 |
0.046 |
| gga04630 |
Jak-STAT signaling pathway |
21 |
1.4 |
0.044 |
11 |
1.2 |
0.028 |
| gga04270 |
Vascular smooth muscle contraction |
18 |
1.2 |
0.015 |
14 |
1.5 |
0.0047 |
| gga04110 |
Cell cycle |
14 |
0.9 |
0.028 |
3 |
0.3 |
0.099 |
| gga04910 |
Insulin signaling pathway |
14 |
0.9 |
0.039 |
|
|
|
| gga04512 |
ECM-receptor interaction |
13 |
0.9 |
0.0156 |
10 |
1.1 |
0.028 |
| gga03320 |
PPAR signaling pathway |
12 |
0.8 |
0.033 |
4 |
0.4 |
0.01 |
| gga04916 |
Melanogenesis |
12 |
0.8 |
0.023 |
14 |
1.5 |
0.0015 |
| gga00590 |
Arachidonic acid metabolism |
11 |
0.7 |
0.02 |
2 |
0.2 |
0.095 |
| gga04370 |
VEGF signaling pathway |
11 |
0.7 |
0.011 |
2 |
0.2 |
0.0015 |
| gga04540 |
Gapjunction |
11 |
0.7 |
0.024 |
14 |
1.5 |
0.00056 |
| gga04350 |
TGF-beta signaling pathway |
10 |
0.7 |
0.034 |
4 |
0.4 |
0.023 |
| gga04012 |
ErbB signaling pathway |
9 |
0.6 |
0.048 |
3 |
0.3 |
0.034 |
| gga04914 |
Progesterone-mediated oocyte maturation |
9 |
0.6 |
0.047 |
|
|
|
| gga04920 |
Adipocytokine signaling pathway |
9 |
0.6 |
0.022 |
|
|
|
| gga00564 |
Glycerophospholipid metabolism |
8 |
0.5 |
0.037 |
5 |
0.5 |
0.047 |
| gga04070 |
Phosphatidylinositol signaling system |
8 |
0.5 |
0.046 |
|
|
|
| gga00260 |
Glycine, serine and threonine metabolism |
6 |
0.4 |
0.012 |
6 |
0.6 |
0.02 |
| gga00512 |
O-Glycan biosynthesis |
6 |
0.4 |
0.011 |
3 |
0.3 |
0.046 |
| gga00601 |
Glycosphingolipid biosynthesis-Lacto |
6 |
0.4 |
0.019 |
2 |
0.2 |
0.033 |
| gga03030 |
DNA replication |
6 |
0.4 |
0.02 |
|
|
|
| gga04672 |
Intestinal immune network for IgA production |
6 |
0.4 |
0.042 |
5 |
0.5 |
0.024 |
| gga00565 |
Ether lipid metabolism |
5 |
0.3 |
0.036 |
|
|
|
| gga00592 |
alpha-Linolenic acid metabolism |
4 |
0.3 |
0.02 |
|
|
|
| gga00603 |
Glycosphingolipid biosynthesis |
4 |
0.3 |
0.011 |
|
|
|
| gga04320 |
Dorso-ventral axis formation |
4 |
0.3 |
0.037 |
|
|
|
| gga00604 |
Glycosphingolipid biosynthesis |
3 |
0.2 |
0.038 |
|
|
|
| gga00910 |
Nitrogen metabolism |
|
|
|
4 |
0.4 |
0.011 |
| gga04260 |
Cardiac muscle contraction |
|
|
|
7 |
0.7 |
0.021 |
| gga04340 |
Hedgehog signaling pathway |
|
|
|
8 |
0.8 |
0.024 |
